Performance Evaluation of the Lucira COVID-19 & Flu Test

NACompletedINTERVENTIONAL
Enrollment

1,361

Participants

Timeline

Start Date

October 11, 2022

Primary Completion Date

February 16, 2023

Study Completion Date

February 16, 2023

Conditions
COVID-19Influenza
Interventions
DEVICE

Lucira COVID-19 & Flu Test

The Lucira COVID-19 \& Flu Test is a rapid, single-use, molecular test for the qualitative detection and discrimination of SARS-CoV-2, Influenza A, and Influenza B viral RNA in nasal swab samples.

Trial Locations (7)

35055

Cullman Clinical Trials, Cullman

61550

Koch Family Medicine, Morton

76904

Benchmark Research, San Angelo

92324

Benchmark Research, Colton

94610

Carbon Health, Oakland

03264

Lakeside Life Science, Plymouth

07724

Carbon Health, Eatontown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lucira Health Inc

INDUSTRY